article thumbnail

Aseptic packaging market to value $35bn by 2033

European Pharmaceutical Review

According to a report by Research Nester, the global aseptic packaging market is projected to reach a revenue of $35 billion by 2033 and is estimated to reach a compound annual growth rate (CAGR) of 10 percent between 2023 and 2033. The post Aseptic packaging market to value $35bn by 2033 appeared first on European Pharmaceutical Review.

article thumbnail

Pharma contract manufacturing market to grow to $130bn by 2026

European Pharmaceutical Review

billion by 2026. percent between 2021 and 2026 (the forecast period). Billion by 2026, achieving a 5.6 According to the report, the packaging segment of the market will be worth $15.6 For instance, efforts are underway to automate packaging of personalised cell and gene therapies. billion by the year 2026.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Target investing $100M to expand next-day delivery services

Drug Store News

Target plans to spend $100 million to expand its package-sorting network to more than 15 facilities by the end of 2026.

article thumbnail

Pharmapack Awards 2024 entries open

European Pharmaceutical Review

CPHI’s awards provide insight into the industry’s latest developments and innovations that will influence global drug delivery and packaging in the year ahead. This award is open to entries from products or services in either the proof of concept or prototype stage with a timeline for launch until the end of 2026.

article thumbnail

Novo Nordisk to expand French production facilities

European Pharmaceutical Review

These activities are expected to be completed incrementally between 2026 to 2028, the company stated. Novo Nordisk declared that it will help to boost its global capacity, “from manufacturing of active pharmaceutical ingredients (API) through to packaging.” Construction has already begun.

article thumbnail

Construction starts on $400m biosimilars production centre in Slovenia

European Pharmaceutical Review

The centre, which will create up to 330 new jobs in the region, is expected to be operational by the end of 2026. The new biosimilars production centre will also include facilities for manufacturing and storage. The site employs 775 people full time, Sandoz said.

article thumbnail

WuXi STA breaks ground on new Delaware manufacturing facility

European Pharmaceutical Review

The second facility for WuXi STA in the US, Phase I of the new campus will provide formulation development, clinical and commercial drug product manufacturing services for a variety of oral and injectable dosage forms, as well as packaging, labelling, storage and distribution services for clinical trial materials and commercial drug products.